Jan M. Sap
8Patents
3h-index
6Co-inventors
46Inventor score
Filing activity: Feb 10, 1993 → Feb 13, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5861266A | Treatment of diabetes mellitus and insulin receptor signal transduction | Human Necessities | 8 | Expired |
| US5538886A | Receptor-type phosphotyrosine phosphatase-alpha | Chemistry; Metallurgy | 8 | Expired |
| US5856162A | Receptor-type phosphotyrosine phosphatase-.kappa. | Chemistry; Metallurgy | 6 | Expired |
| US5888794A | Receptor-type phosphotyrosine phosphatase-alpha | Chemistry; Metallurgy | 3 | Expired |
| US5863755A | Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-.kappa. | Chemistry; Metallurgy | 1 | Expired |
| US7108994B2 | Receptor-type phosphotyrosine phosphatase-alpha | Chemistry; Metallurgy | 0 | Expired |
| US6682905B1 | Receptor-type phosphotyrosine phosphatase-alpha | Chemistry; Metallurgy | 0 | Expired |
| US7056508B2 | Receptor-type phosphotyrosine phosphatase-kappa antibodies | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.